Synthesis and cytotoxic evaluation of some novel 3-2-(2-phenyl-thiazol-4-yl)-ethyl -3H-pyrido 2,3-dpyrimidin-4-one derivatives

(2021) Synthesis and cytotoxic evaluation of some novel 3-2-(2-phenyl-thiazol-4-yl)-ethyl -3H-pyrido 2,3-dpyrimidin-4-one derivatives. RESEARCH IN PHARMACEUTICAL SCIENCES. pp. 455-463. ISSN 1735-5362 1735-9414 J9 - RES PHARM SCI

Full text not available from this repository.

Abstract

Background and purpose: Pyridopyrimidine and its derivatives have a variety of chemical and biological significances. Thiazole-containing compounds have also been reported to have a wide range of biological activities. Due to the valuable cytotoxic effects of both thiazole and pyridopyrimidinone derivatives, a series of pyridopyrimidinone-thiazole hybrids were synthesized in the present study. Experimental approach: Briefly, different acyl chlorides were reacted with 2-amino nicotinic acid followed by anhydride acetic to give the corresponding pyridobenzoxazinones. The aminothiazole derivative G was also prepared via a multistep procedure and incorporated into the benzoxazinones to furnish the target pyridopyrimidinone, K1-K5. Furthermore, the cytotoxic activity of the final compounds was determined against MCF-7 and HeLa cell lines using MTT assay. Findings/Results: The results indicated that aromatic substitution on C2 of pyridopyrimidine nucleus was in favor of cytotoxic activity on both cell lines, of which, compound K5 bearing a chlorophenyl group showed the highest cytotoxicity. Conclusion and implications: The results of the present study are valuable in terms of synthesis of hybrid molecules and also cytotoxic evaluations which can be useful for future investigations about the design of novel pyridopyrimidinone-thiazole hybrids possessing better cytotoxic activities.

Item Type: Article
Keywords: Cytotoxicity Pyridopyrimidine Thiazole IN-VITRO TYROSINE KINASE ANTIBACTERIAL AGENTS INHIBITORS DESIGN
Page Range: pp. 455-463
Journal or Publication Title: RESEARCH IN PHARMACEUTICAL SCIENCES
Journal Index: ISI
Volume: 16
Number: 5
Identification Number: https://doi.org/10.4103/1735-5362.323912
ISSN: 1735-5362 1735-9414 J9 - RES PHARM SCI
Depositing User: Zahra Otroj
URI: http://eprints.mui.ac.ir/id/eprint/17198

Actions (login required)

View Item View Item